The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE

Tissue Antigens

Volumn 71, Issue 2, 2008, Pages 114-126

  Tsai, L J ^a   Hsiao, S H ^b,c   Tsai, L M ^a   Lin, C Y ^d,e,f   Tsai, J J ^g   Liou, D M ^b   Lan, J L ^g  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Autoimmune modifier gene; Candidate gene association approach; Data mining; Sodium dependent glucose cotransporter; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; FAS LIGAND; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LYMPHOTOXIN; SM ANTIBODY; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 11; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALOPECIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOIMMUNITY; FEMALE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SODIUM-GLUCOSE TRANSPORT PROTEINS;

EID: 38049168735     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00975.x     Document Type: Article

References (54)

1. Marshall E. Lupus: mysterious disease holds its secrets tight. Science 2002: 296: 689 91.
2. Tsokos GC. Systemic lupus erythematosus. A disease with a complex pathogenesis. Lancet 2001: 358 (Suppl S65.
3. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003: 56: 481 90.
4. Gaffney PM, Ortmann WA, Selby SA et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000: 66: 547 56.
5. Shai R, Quismorio FP Jr., Li L et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999: 8: 639 44.
6. Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A 1998: 95: 14875 9.
7. Lee YH, Nath SK. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 2005: 118: 434 43.
8. Gillett CD, Langefeld CD, Williams AH et al. Fine mapping chromosome 16q12 in a collection of 231 systemic lupus erythematosus sibpair and multiplex families. Genes Immun 2005: 6: 19 23.
9. Cantor RM, Yuan J, Napier S, et al. Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum 2004: 50: 3203 10.
10. Tamiya G, Shinya M, Imanishi T et al. Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet 2005: 14: 2305 21.
11. Fisher SA, Lanchbury JS, Lewis CM. Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16. Arthritis Rheum 2003: 48: 1200 6.
12. Karason A, Gudjonsson JE, Jonsson HH et al. Genetics of psoriasis in Iceland: evidence for linkage of subphenotypes to distinct Loci. J Invest Dermatol 2005: 124: 1177 85.
13. Karason A, Gudjonsson JE, Upmanyu R et al. A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet 2003: 72: 125 31.
14. Karasneh J, Gul A, Ollier WE, Silman AJ, Worthington J. Whole-genome screening for susceptibility genes in multicase families with Behcet's disease. Arthritis Rheum 2005: 52: 1836 42.
15. Zouali H, Chamaillard M, Lesage S et al. Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet 2001: 9: 731 42.
16. Farmer M, Hunt L, Eichenberger MR, Petras RE, Janosky JE, Galandiuk S. Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease. Dig Dis Sci 2001: 46: 632 6.
17. Tsao BP, Cantor RM, Grossman JM et al. Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2002: 46: 2928 36.
18. Weiner SM, Otte A, Schumacher M et al. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. Lupus 2000: 9: 386 9.
19. Sheu ML, Ho FM, Yang RS et al. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol 2005: 25: 539 45.
20. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 2005: 16: 705 13 (Epub 8 August 2005).
21. Koubi D, Jiang H, Zhang L et al. Role of Bcl-2 family of proteins in mediating apoptotic death of PC12 cells exposed to oxygen and glucose deprivation. Neurochem Int 2005: 46: 73 81.
22. Fogal B, Hewett JA, Hewett SJ. Interleukin-1beta potentiates neuronal injury in a variety of injury models involving energy deprivation. J Neuroimmunol 2005: 161: 93 100.
23. Mahoney JA, Rosen A. Apoptosis and autoimmunity. Curr Opin Immunol 2005: 17: 583 8.
24. Kim H, McGrath BM, Silverstone PH. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders-focus on magnetic resonance spectroscopy (MRS) studies. Hum Psychopharmacol 2005: 20: 309 26.
25. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994: 265: 2037 48.
26. Han J, Kamber M. Data Mining: Concepts and Techniques. San Francisco: Morgan Kaufmann, 2001.
27. Stilou S, Bamidis PD, Maglaveras N, Pappas C. Mining association rules from clinical databases: an intelligent diagnostic process in healthcare. Medinfo 2001: 10: 1399 403.
28. Doddi S, Marathe A, Ravi SS, Torney DC. Discovery of association rules in medical data. Med Inform Internet Med 2001: 26: 25 33.
29. Creighton C, Hanash S. Mining gene expression databases for association rules. Bioinformatics 2003: 19: 79 86.
30. Tsao BP. An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 2002: 4: 359 67.
31. Tsao BP, Grossman JM. Genetics and systemic lupus erythematosus. Curr Rheumatol Rep 2001: 3: 183 90.
32. Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol 2001: 167: 90 7.
33. Bennett F, Luxenberg D, Ling V et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003: 170: 711 8.
34. Waterston AM, Salway F, Andreakos E, Butler DM, Feldmann M, Coombes RC. TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model. Br J Cancer 2004: 90: 1279 84.
35. Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1998: 41: 344 53.
36. Sullivan KE, Jawad AF, Piliero LM et al. Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford) 2003: 42: 446 52.
37. Lane SK, Gravel JW Jr. Clinical utility of common serum rheumatologic tests. Am Fam Physician 2002: 65: 1073 80.
38. ACR AD HOC Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999: 42: 599 608.
39. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003: 33 (Suppl 228 37.
40. Hung SI, Chung WH, Liou LB et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 2005: 102: 4134 9.
41. Kell DB. Genotype-phenotype mapping: genes as computer programs. Trends Genet 2002: 18: 555 9.
42. Frank E, Hall M, Trigg L, Holmes G, Witten IH. Data mining in bioinformatics using Weka. Bioinformatics 2004: 20: 2479 81.
43. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005: 21: 263 5.
44. McCarthy MI. Susceptibility gene discovery for common metabolic and endocrine traits. J Mol Endocrinol 2002: 28: 1 17.
45. Lin SC, Yen JH, Tsai JJ et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004: 50: 770 5.
46. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 2005: 16: 705 13.
47. Higgins BD, Kane MT. Inositol transport in mouse embryonic stem cells. Reprod Fertil Dev 2005: 17: 633 9.
48. Bissonnette P, Coady MJ, Lapointe JY. Expression of the sodium-myo-inositol cotransporter SMIT2 at the apical membrane of Madin-Darby canine kidney cells. J Physiol 2004: 558: 759 68 (Epub 4 June 2004).
49. Chauvin TR, Griswold MD. Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium. Biol Reprod 2004: 70: 744 51.
50. Warskulat U, Reinen A, Grether-Beck S, Krutmann J, Haussinger D. The osmolyte strategy of normal human keratinocytes in maintaining cell homeostasis. J Invest Dermatol 2004: 123: 516 21.
51. Vucenik I, Shamsuddin AM. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr 2003: 133 (11 Suppl 1 3778 84S.
52. Rao DC, Gu C. False positives and false negatives in genome scans. Adv Genet 2001: 42: 487 98.
53. Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 2007: 31: 358 62.
54. Rao DC, Province MA. Genetic Dissection of Complex Traits. San Diego: Academic Press, 2001.